Harmony Biosciences Holdings, Inc. (HRMY)
$39.21-$0.66 (-1.66%) Today
Latest HRMY Insider Trades
Sandip Kapadia - Officer
Sandip Kapadia - OfficerSandip Kapadia - OfficerSandip Kapadia - OfficerSandip Kapadia - OfficerHarmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.
https://www.harmonybiosciences.comSEC filings for HRMY on EDGAR
No Form 4 activity for HRMY in the last 90 days.
29 Form 4 filings on record, the earliest from Oct 1, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Geno J. Germano | Grant or award | Stock Option | 21,231 | $0.00 | - | |
 Linda M. Szyper | Grant or award | Stock Option | 21,872 | $0.00 | - | |
 Ron M. Philip | Grant or award | Stock Option | 21,872 | $0.00 | - | |
| R. Mark Graf | Grant or award | Stock Option | 21,872 | $0.00 | - | |
| Juan A. Sabater | Grant or award | Stock Option | 21,872 | $0.00 | - | |
| Gary Sender | Grant or award | Stock Option | 21,872 | $0.00 | - | |
| Kumar Budur - Officer | Option exercise | Common Stock | 18,750 | $0.00 | - | |
| Kumar Budur - Officer | Tax withholding / forfeiture | Common Stock | 8,882 | $31.83 | $283K | |
| Kumar Budur - Officer | Option exercise | Restricted Stock Units | 18,750 | $0.00 | - | |
 Glenn Reicin - Officer | Grant or award | Stock Option | 164,309 | $0.00 | - | |
| Adam H. Zaeske - Officer | Option exercise | Common Stock | 7,500 | $0.00 | - | |
| Adam H. Zaeske - Officer | Tax withholding / forfeiture | Common Stock | 3,173 | $27.62 | $88K | |
| Adam H. Zaeske - Officer | Option exercise | Restricted Stock Units | 7,500 | $0.00 | - | |
| Peter Anastasiou - Officer | Grant or award | Stock Option | 212,241 | $0.00 | - | |
 Troy A. Ignelzi | Grant or award | Stock Option | 17,710 | $0.00 | - | |
| Sandip Kapadia - Officer | Open-market sale | Common Stock | 3,746 | $37.15 | $139K | |
| Sandip Kapadia - Officer | Option exercise | Common Stock | 3,813 | $0.00 | - | |
| Sandip Kapadia - Officer | Option exercise | Common Stock | 4,725 | $0.00 | - | |
| Sandip Kapadia - Officer | Tax withholding / forfeiture | Common Stock | 2,239 | $36.82 | $82K | |
| Sandip Kapadia - Officer | Tax withholding / forfeiture | Common Stock | 2,553 | $36.82 | $94K | |
| Sandip Kapadia - Officer | Grant or award | Stock Option | 42,600 | $0.00 | - | |
| Sandip Kapadia - Officer | Grant or award | Restricted Stock Units | 12,200 | $0.00 | - | |
| Sandip Kapadia - Officer | Option exercise | Restricted Stock Units | 3,813 | $0.00 | - | |
| Sandip Kapadia - Officer | Option exercise | Restricted Stock Units | 4,725 | $0.00 | - | |
| Andrew Serafin - Officer | Option exercise | Common Stock | 2,500 | $0.00 | - | |
| Andrew Serafin - Officer | Option exercise | Common Stock | 2,600 | $0.00 | - | |
| Andrew Serafin - Officer | Tax withholding / forfeiture | Common Stock | 1,116 | $36.82 | $41K | |
| Andrew Serafin - Officer | Tax withholding / forfeiture | Common Stock | 1,126 | $36.82 | $41K | |
| Andrew Serafin - Officer | Grant or award | Stock Option | 42,600 | $0.00 | - | |
| Andrew Serafin - Officer | Grant or award | Restricted Stock Units | 12,200 | $0.00 | - | |
| Andrew Serafin - Officer | Option exercise | Restricted Stock Units | 2,500 | $0.00 | - | |
| Andrew Serafin - Officer | Option exercise | Restricted Stock Units | 2,600 | $0.00 | - | |
| Kumar Budur - Officer | Option exercise | Common Stock | 2,188 | $0.00 | - | |
| Kumar Budur - Officer | Option exercise | Common Stock | 2,662 | $0.00 | - | |
| Kumar Budur - Officer | Tax withholding / forfeiture | Common Stock | 1,153 | $36.82 | $42K | |
| Kumar Budur - Officer | Tax withholding / forfeiture | Common Stock | 1,372 | $36.82 | $51K | |
| Kumar Budur - Officer | Grant or award | Stock Option | 42,600 | $0.00 | - | |
| Kumar Budur - Officer | Grant or award | Restricted Stock Units | 12,200 | $0.00 | - | |
| Kumar Budur - Officer | Option exercise | Restricted Stock Units | 2,188 | $0.00 | - | |
| Kumar Budur - Officer | Option exercise | Restricted Stock Units | 2,662 | $0.00 | - | |
| Adam H. Zaeske - Officer | Grant or award | Stock Option | 56,900 | $0.00 | - | |
| Adam H. Zaeske - Officer | Grant or award | Restricted Stock Units | 16,200 | $0.00 | - | |
| Jeffrey M. Dayno - Officer | Option exercise | Common Stock | 10,500 | $0.00 | - | |
| Jeffrey M. Dayno - Officer | Option exercise | Common Stock | 13,000 | $0.00 | - | |
| Jeffrey M. Dayno - Officer | Tax withholding / forfeiture | Common Stock | 4,785 | $36.82 | $176K | |
| Jeffrey M. Dayno - Officer | Tax withholding / forfeiture | Common Stock | 5,654 | $36.82 | $208K | |
| Jeffrey M. Dayno - Officer | Grant or award | Stock Option | 184,600 | $0.00 | - | |
| Jeffrey M. Dayno - Officer | Grant or award | Restricted Stock Units | 52,900 | $0.00 | - | |
| Jeffrey M. Dayno - Officer | Option exercise | Restricted Stock Units | 10,500 | $0.00 | - | |
| Jeffrey M. Dayno - Officer | Option exercise | Restricted Stock Units | 13,000 | $0.00 | - | |
| Sandip Kapadia - Officer | Open-market sale | Common Stock | 20,961 | $35.92 | $753K | |
| Sandip Kapadia - Officer | Open-market sale | Common Stock | 3,427 | $35.00 | $120K | |
| Sandip Kapadia - Officer | Option exercise | Common Stock | 45,000 | $0.00 | - | |
| Sandip Kapadia - Officer | Tax withholding / forfeiture | Common Stock | 24,039 | $27.56 | $663K | |
| Sandip Kapadia - Officer | Option exercise | Restricted Stock Units | 45,000 | $0.00 | - | |
| Valor IV Pharma Holdings, LLC - 10% Owner | Other | Common Stock | 6,618,033 | - | - | |
| Sandip Kapadia - Officer | Open-market sale | Common Stock | 21,573 | $36.50 | $787K | |
| Valor IV Pharma Holdings, LLC - 10% Owner | Open-market sale | Common Stock | 4,000,000 | $30.30 | $121.21M | |
| Valor IV Pharma Holdings, LLC - 10% Owner | Open-market sale | Common Stock | 600,000 | $30.30 | $18.18M | |
| Marshman Fund Trust II - 10% Owner | Open-market sale | Common Stock | 4,000,000 | $30.30 | $121.21M | |
| Marshman Fund Trust II - 10% Owner | Open-market sale | Common Stock | 600,000 | $30.30 | $18.18M | |
| Jeffrey Dierks - Officer | Option exercise | Common Stock | 21,496 | $24.00 | $516K | |
| Jeffrey Dierks - Officer | Open-market sale | Common Stock | 21,496 | $40.47 | $870K | |
| Jeffrey Dierks - Officer | Option exercise | Stock Option | 21,496 | $0.00 | - | |
| Jeffrey Dierks - Officer | Open-market sale | Common Stock | 35,652 | $35.05 | $1.25M | |
| Jeffrey Dierks - Officer | Open-market sale | Common Stock | 705 | $35.62 | $25K | |
| Sandip Kapadia - Officer | Option exercise | Common Stock | 60,000 | $0.00 | - | |
| Sandip Kapadia - Officer | Tax withholding / forfeiture | Common Stock | 32,052 | $40.00 | $1.28M | |
| Sandip Kapadia - Officer | Option exercise | Restricted Stock Units | 60,000 | $0.00 | - | |
| Jeffrey Dierks - Officer | Option exercise | Common Stock | 60,000 | $0.00 | - | |
| Jeffrey Dierks - Officer | Tax withholding / forfeiture | Common Stock | 23,643 | $40.00 | $946K | |
| Jeffrey Dierks - Officer | Option exercise | Restricted Stock Units | 60,000 | $0.00 | - | |
| Jeffrey Dierks - Officer | Option exercise | Common Stock | 35,846 | $24.00 | $860K | |
| Jeffrey Dierks - Officer | Open-market sale | Common Stock | 35,846 | $40.03 | $1.43M | |
| Jeffrey Dierks - Officer | Option exercise | Stock Option | 35,846 | $0.00 | - |
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| VALOR IV PHARMA HOLDINGS LLC | Director | 700,883 | $26.56M | View on EDGAR | |
| - | - | - | - | View on EDGAR | |
| - | - | - | - | View on EDGAR |
Harmony Biosciences Holdings, Inc. (HRMY) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-05-19. The full record for HRMY runs to 29 Form 4 filings, the earliest from 2024-10-01. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of HRMY were filed in the last 90 days.
No insider sales of HRMY were filed in the last 90 days. 12 sales are on record for this company.
This page tracks HRMY Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add HRMY to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
